Specialization
Medical Oncology
Focus of research
Pancreatic cancer; cancer subtypes
-
KRAS mutation status integrated with RNA subtyping improves prognostic modeling in FOLFIRINOX-treated metastatic pancreatic cancer
Lansbergen, M. F., Dings, M. P. G., Koster, J., Labots, M., Kerver, E. D., Jochems, A., Homs, M. Y. V., de Vos-Geelen, J., Hendriks, M. P., Tanck, M. W. T., Wilmink, J. W., van Laarhoven, H. W. M. & Bijlsma, M. F., 13 Jun 2025, In: Med. 6, 6, 100601.Research output: Contribution to journal › Article* › Academic › peer-review
-
Transcriptome-based classification to predict FOLFIRINOX response in a real-world metastatic pancreatic cancer cohort
Lansbergen, M. F., Dings, M. P. G., Manoukian, P., Fariña, A., Waasdorp, C., Hooijer, G. K. J., Verheij, J., Koster, J., Zwijnenburg, D. A., Wilmink, J. W., Medema, J. P., Dijk, F., van Laarhoven, H. W. M. & Bijlsma, M. F., 1 Nov 2024, In: Translational research. 273, p. 137-147 11 p.Research output: Contribution to journal › Article* › Academic › peer-review
-
Poor-prognosis molecular subtypes in adenocarcinomas of pancreato-biliary and gynecological origin: A systematic review
Lansbergen, M. F., Khelil, M., Etten – Jamaludin, F. S. V., Bijlsma, M. F. & van Laarhoven, H. W. M., 1 May 2023, In: Critical reviews in oncology/hematology. 185, 103982.Research output: Contribution to journal › Review article* › Academic › peer-review
- All publications